Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial | 17.05.21

Nachrichten Ticker – www.finanzen.ch SHANGHAI and HONG KONG, May 17, 2021 /PRNewswire/ — Antengene Corporation Limited („Antengene“, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated…

Mehr anzeigen Antengene Announces the Completion of the Quantitative and Systems Pharmacology Modeling for ATG-101 in Preparation for First-in-Human Trial | 17.05.21

ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hy… | 16.05.21

Nachrichten Ticker – www.finanzen.ch PALO ALTO, Calif., May 16, 2021 /PRNewswire/ — ReCor Medical, Inc. („ReCor“), a wholly-owned subsidiary of Otsuka Medical Devices Co., Ltd., today presented…

Mehr anzeigen ReCor Medical Announces Results from Landmark RADIANCE-HTN TRIO Study, Showing Clinically Significant Blood Pressure Reduction with the Paradise Ultrasound RDN System in Patients with Resistant Hy… | 16.05.21